- Investing Ideas
- Danish Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Danish Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
2
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
2 companies
ALK-Abelló
Market Cap: DKK 45.6b
An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.
ALK B
DKK 205.80
7D
1.9%
1Y
45.9%
ChemoMetec
Market Cap: DKK 5.4b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 309.00
7D
6.6%
1Y
-27.3%